• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织转谷氨酰胺酶和因子 XIII 在软骨与骨重塑中的作用

Tissue transglutaminase and factor XIII in cartilage and bone remodeling.

作者信息

Aeschlimann D, Mosher D, Paulsson M

机构信息

Department of Medicine, University of Wisconsin, Madison 53792-3228, USA.

出版信息

Semin Thromb Hemost. 1996;22(5):437-43. doi: 10.1055/s-2007-999043.

DOI:10.1055/s-2007-999043
PMID:8989828
Abstract

While it is well established that factor XIII functions in crosslinking of the fibrin clot during blood coagulation and in wound healing, the physiological role of tissue transglutaminase is still unclear. Recent studies suggest that the expression of tissue transglutaminase correlates with (terminal) differentiation of cells and that the enzyme may play a role in extracellular matrix remodeling. In cartilage, tissue transglutaminase expression is restricted to hypertrophic chondrocytes and the enzyme is externalized at a distinct step in the chondrocyte maturation program. Upon activation by Ca2+, the transglutaminase modifies matrix constituents in a way that might predispose the matrix for the subsequent mineralization. Crosslinks of the structure gamma-glutamyl-epsilon-lysine are also abundant in bone matrix, but the transglutaminase expressed by osteoblasts and presumably involved in crosslinking of newly formed osteoid is likely to be distinct from both tissue transglutaminase and factor XIII. Matrix proteins thought to be crosslinked by transglutaminases in cartilage and bone matrix include glycoproteins such as osteonectin, osteopontin, fibronectin, fibrillin, and collagens II, III, V, and XI. Expression of the A subunit of factor XIII is restricted to megakaryocytes in the bone marrow cavity, and factor XIIIa is abundant in platelets that probably provide the major source for factor XIII in plasma.

摘要

虽然已经明确因子 XIII 在血液凝固过程中的纤维蛋白凝块交联以及伤口愈合中发挥作用,但组织转谷氨酰胺酶的生理作用仍不清楚。最近的研究表明,组织转谷氨酰胺酶的表达与细胞的(终末)分化相关,并且该酶可能在细胞外基质重塑中发挥作用。在软骨中,组织转谷氨酰胺酶的表达仅限于肥大软骨细胞,并且该酶在软骨细胞成熟程序的一个特定阶段被分泌到细胞外。在 Ca2+ 激活后,转谷氨酰胺酶以一种可能使基质易于随后矿化的方式修饰基质成分。γ-谷氨酰-ε-赖氨酸结构的交联在骨基质中也很丰富,但成骨细胞表达的、可能参与新形成类骨质交联的转谷氨酰胺酶可能与组织转谷氨酰胺酶和因子 XIII 都不同。在软骨和骨基质中被认为由转谷氨酰胺酶交联的基质蛋白包括糖蛋白,如骨连接蛋白、骨桥蛋白、纤连蛋白、原纤维蛋白以及胶原蛋白 II、III、V 和 XI。因子 XIII 的 A 亚基的表达仅限于骨髓腔中的巨核细胞,并且因子 XIIIa 在血小板中含量丰富,血小板可能是血浆中因子 XIII 的主要来源。

相似文献

1
Tissue transglutaminase and factor XIII in cartilage and bone remodeling.组织转谷氨酰胺酶和因子 XIII 在软骨与骨重塑中的作用
Semin Thromb Hemost. 1996;22(5):437-43. doi: 10.1055/s-2007-999043.
2
Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII.组织型转谷氨酰胺酶缺陷小鼠中小动脉的血流依赖性重塑:巨噬细胞衍生的因子XIII可能的补偿作用
Circ Res. 2006 Jul 7;99(1):86-92. doi: 10.1161/01.RES.0000229657.83816.a7. Epub 2006 Jun 1.
3
Regulation of transglutaminase activity in articular chondrocytes through thrombin receptor-mediated factor XIII synthesis.通过凝血酶受体介导的因子XIII合成调节关节软骨细胞中的转谷氨酰胺酶活性。
Thromb Haemost. 2004 Mar;91(3):558-68. doi: 10.1160/TH03-07-0462.
4
Regulation of bone development and extracellular matrix protein genes by RUNX2.RUNX2 对骨骼发育和细胞外基质蛋白基因的调控。
Cell Tissue Res. 2010 Jan;339(1):189-95. doi: 10.1007/s00441-009-0832-8. Epub 2009 Aug 1.
5
Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures.纤维连接蛋白在成骨细胞培养物中从基质转换为稳定状态需要凝血因子 XIIIa 产生的转谷氨酰胺酶活性。
Bone. 2014 Feb;59:127-38. doi: 10.1016/j.bone.2013.11.006. Epub 2013 Nov 15.
6
Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate.转谷氨酰胺酶催化分化软骨中的基质交联:骨连接蛋白作为主要谷氨酰胺底物的鉴定。
J Cell Biol. 1995 May;129(3):881-92. doi: 10.1083/jcb.129.3.881.
7
Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.转谷氨酰胺酶活性调节MC3T3-E1成骨细胞培养中的成骨细胞分化和基质矿化。
Matrix Biol. 2006 Apr;25(3):135-48. doi: 10.1016/j.matbio.2005.11.001. Epub 2006 Feb 15.
8
Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.先天性缺乏血浆因子XIII的患者的单核细胞缺乏因子XIII亚基a抗原和转谷氨酰胺酶活性。
Thromb Haemost. 1988 Apr 8;59(2):231-5.
9
Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.凝血因子 XIII:一种具有多种血浆和细胞功能的凝血因子。
Physiol Rev. 2011 Jul;91(3):931-72. doi: 10.1152/physrev.00016.2010.
10
Transglutaminase factor XIIIA in the cartilage of developing avian long bones.发育中禽类长骨软骨中的转谷氨酰胺酶因子 XIIIA
Dev Dyn. 2002 Jan;223(1):24-32. doi: 10.1002/dvdy.1230.

引用本文的文献

1
In silico studies of the open form of human tissue transglutaminase.人组织转谷氨酰胺酶开放形式的计算机模拟研究。
Sci Rep. 2024 Jul 10;14(1):15981. doi: 10.1038/s41598-024-66348-8.
2
F13A1 transglutaminase expression in human adipose tissue increases in acquired excess weight and associates with inflammatory status of adipocytes.人脂肪组织中 F13A1 转谷氨酰胺酶的表达随着获得性超重而增加,并与脂肪细胞的炎症状态相关。
Int J Obes (Lond). 2021 Mar;45(3):577-587. doi: 10.1038/s41366-020-00722-0. Epub 2020 Nov 21.
3
Emerging Technologies and Platforms for the Immunodetection of Multiple Biochemical Markers in Osteoarthritis Research and Therapy.
骨关节炎研究与治疗中多种生化标志物免疫检测的新兴技术与平台
Front Med (Lausanne). 2020 Oct 21;7:572977. doi: 10.3389/fmed.2020.572977. eCollection 2020.
4
Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity.人组织转谷氨酰胺酶 2 结构:寻找干扰交联介导活性的线索。
Int J Mol Sci. 2020 Mar 23;21(6):2225. doi: 10.3390/ijms21062225.
5
Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.转谷氨酰胺酶因子XIII - A和TG2调节骨骼和骨髓中的吸收、脂肪生成以及血浆纤连蛋白稳态。
Cell Death Differ. 2017 May;24(5):844-854. doi: 10.1038/cdd.2017.21. Epub 2017 Apr 7.
6
Advances of Coagulation Factor XIII.凝血因子 XIII 的研究进展
Chin Med J (Engl). 2017 Jan 20;130(2):219-223. doi: 10.4103/0366-6999.198007.
7
Inhibition of tissue transglutaminase promotes Aβ-induced apoptosis in SH-SY5Y cells.抑制组织转谷氨酰胺酶可促进淀粉样β蛋白诱导的SH-SY5Y细胞凋亡。
Acta Pharmacol Sin. 2016 Dec;37(12):1534-1542. doi: 10.1038/aps.2016.95. Epub 2016 Sep 26.
8
Tissue Transglutaminase and Its Product Isopeptide Are Increased in Alzheimer's Disease and APPswe/PS1dE9 Double Transgenic Mice Brains.组织转谷氨酰胺酶及其产物异肽在阿尔茨海默病和APPswe/PS1dE9双转基因小鼠大脑中增加。
Mol Neurobiol. 2016 Oct;53(8):5066-78. doi: 10.1007/s12035-015-9413-x. Epub 2015 Sep 19.
9
Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.转谷氨酰胺酶因子XIII通过与炎症和骨侵蚀相关的机制促进关节炎。
Blood. 2015 Jan 15;125(3):427-37. doi: 10.1182/blood-2014-08-594754. Epub 2014 Oct 21.
10
Megakaryocytes are mechanically responsive and influence osteoblast proliferation and differentiation.巨核细胞具有机械反应性,并影响成骨细胞的增殖和分化。
Bone. 2014 Sep;66:111-20. doi: 10.1016/j.bone.2014.05.015. Epub 2014 Jun 2.